PFM Health Sciences’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $38.3M | Buy |
221,754
+34,838
| +19% | +$6.01M | 3.26% | 7 |
|
2025
Q1 | $29.1M | Buy |
186,916
+134,524
| +257% | +$21M | 2.12% | 14 |
|
2024
Q4 | $7.21M | Sell |
52,392
-38,374
| -42% | -$5.28M | 0.45% | 42 |
|
2024
Q3 | $13.6M | Buy |
+90,766
| New | +$13.6M | 0.77% | 32 |
|
2023
Q2 | – | Sell |
-202,115
| Closed | -$21.7M | – | 80 |
|
2023
Q1 | $21.7M | Buy |
+202,115
| New | +$21.7M | 0.96% | 40 |
|
2019
Q1 | – | Sell |
-27,519
| Closed | -$1.72M | – | 91 |
|
2018
Q4 | $1.72M | Buy |
+27,519
| New | +$1.72M | 0.05% | 83 |
|